[Expression of bovine interferon gamma in recombinant baculovirus and determination of its antiviral activity].

Wei Sheng Wu Xue Bao

Key Laboratory of National Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agriculture Science, Harbin 150001, China.

Published: June 2007

The full-length bovine interferon gamma (BoIFN-gamma) cDNA, including the secretion signal peptide coding region was recloned into baculovirus honor vectors pFastBac 1 of Bac-To-Bac system. These recombinant plasmids, pFastBac 1-BoIFN-gamma, were transformed into DH(10Bac) host bacteria to get recombinant shuttle plasmids, rBacmid-BoIFN-gamma. Recombinant baculovirus, rBac-BoIFN-gamma, was generated for expressing BoIFN-gamma, by transfecting recombinant Bacmid-BoIFN-gamma with Cellfectin Reagen into sf9 insect cells. BoIFN-gamma efficiently expressed by recombinant baculovirus in sf9 cells was testified by indirect immunofluorescence assay and indirect ELISA with monoclonal antibody against Bovine interferon-gamma. Furthermore, VSV * GFP, recombinant Vesicular Stomatitis Virus expressing green fluorescence protein and MDBK were used to determine the anti-viral activity of rBoIFN-gamma. The result shows rBoIFN-gamma could inhibit the replication of the VSV * GFP in MDBK cells and the antiviral activity of supernatant was 2 x 10(5) IU/mL. The antiviral activity of rBoIFN-gamma could be blocked by anti-BoIFN-gamma mouse serum. The results demonstrated that the recombinant baculovirus could express BoIFN-gamma efficiently and rBoIFN-gamma had high antiviral activity.

Download full-text PDF

Source

Publication Analysis

Top Keywords

recombinant baculovirus
16
antiviral activity
12
bovine interferon
8
interferon gamma
8
recombinant
8
boifn-gamma efficiently
8
vsv gfp
8
activity rboifn-gamma
8
baculovirus
5
[expression bovine
4

Similar Publications

Protective humoral immunity induced by virus-like particles expressing Toxoplasma gondii CST1 or MIC8.

Acta Trop

December 2024

Department of Medical Zoology, School of Medicine, Kyung Hee University, Seoul, 02447, Republic of Korea; Medical Research Center for Bioreaction to Reactive Oxygen Species and Biomedical Science Institute, Core Re-search Institute (CRI), Kyung Hee University, Seoul, 02447, Republic of Korea. Electronic address:

Protective efficacy assessment of toxoplasmosis vaccines, at least at the preclinical level, frequently involves lethal dose challenge infection. Nonetheless, their efficacies remain largely unexplored against low infection doses which better reflects how humans become infected in the real world. In this study, we compared the immunity elicited in mice that were heterologously immunized with recombinant baculovirus and virus-like particles expressing either the cyst wall protein (CST1) or microneme protein 8 (MIC8) of Toxoplasma gondii (T.

View Article and Find Full Text PDF

Role of ubiquitin-proteasome pathway in budded virus egress and GP64 surface distribution in Bombyx mori nucleopolyhedrovirus.

J Gen Virol

December 2024

Jiangsu Key Laboratory of Sericultural and Animal Biotechnology, School of Biotechnology, Jiangsu University of Science and Technology, Zhenjiang 212100, PR China.

The Bombyx mori nucleopolyhedrovirus (BmNPV) is a DNA virus that affects the silkworm, , causing substantial economic losses in sericulture. This study investigates the mechanisms underlying budded virus egress, focusing on the roles of the ubiquitin-proteasome pathway (UPP) machinery. BmNPV produces two virion types: budded virions (BVs) and occlusion-derived virions (ODVs), which differ in their envelope origins and functions.

View Article and Find Full Text PDF

Construction with recombinant epitope-expressing baculovirus enhances protective effects of inactivated H9N2 vaccine against heterologous virus.

Vet Microbiol

January 2025

National and Regional Joint Engineering Laboratory for Medicament of Zoonosis Prevention and Control, Guangdong Provincial Key Laboratory of Zoonosis Prevention and Control, College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642,  PR China; UK-China Centre of Excellence for Research on Avian Diseases, Guangzhou 510642, PR China. Electronic address:

Article Synopsis
  • - The study aimed to improve the effectiveness of inactivated H9N2 avian influenza vaccines by combining them with a recombinant baculovirus containing multiple T and B cell epitopes, showing better immune response than using the vaccine alone.
  • - Results indicated that the combined immunization led to significantly higher levels of antibodies and T cell responses, particularly after exposure to a heterologous virus, which suggests a robust immune boost.
  • - The InV+BV-BNT group showed lower viral loads and virus positivity rates in samples taken after infection, highlighting its potential as a supplementary vaccine to enhance protection against H9N2 avian influenza.
View Article and Find Full Text PDF

To study the effects of metabolic enzyme activity inhibition and genetic polymorphisms on the pharmacokinetics and pharmacodynamics of rivaroxaban, we established an in vitro enzymatic reaction system to screen for inhibitors, and used the UPLC-MS/MS method to detect the levels of rivaroxaban and its metabolite M2-1. Additionally, in vivo pharmacokinetic-pharmacodynamic studies were conducted using Sprague-Dawley rats. Human recombinant CYP2J2 baculosomes were prepared using a baculovirus-insect expression system to investigate the impact of genetic polymorphisms on rivaroxaban metabolism through enzyme kinetics methods.

View Article and Find Full Text PDF

Single dose of recombinant baculovirus vaccine expressing sigma B and sigma C genes provides good protection against novel duck reovirus challenge in ducks.

Poult Sci

November 2024

Key Laboratory of Avian Bioproducts Developmen, Ministry of Agriculture and Rural Affairs, China; Jiangsu Co-Innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonosis, Yangzhou University, Yangzhou, Jiangsu, China.

Article Synopsis
  • The novel duck reovirus disease (NDRV) significantly impacts the waterfowl industry, and currently, there are no commercial vaccines available to combat this infection worldwide.
  • Researchers developed two subunit vaccine candidates, σB and σC, using an insect cell-baculovirus expression system (IC-BEVS) to create these vaccines from recombinant viruses targeting NDRV.
  • The study found that a single dose of either σB or σC protein improved immune response and overall health in ducklings better than a traditional whole virus vaccine, with the combination of both subunits showing especially strong protective effects.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!